Skip to main content

Table 1 Baseline characteristics of 136 children with IBD, further divided into CD, UC and IBDU

From: Impact of diagnostic delay to the clinical presentation and associated factors in pediatric inflammatory bowel disease: a retrospective study

  All IBD
n = 136
CD
n = 48
UC
n = 79
IBDU
n = 9
% % % %
Demographic data
 Age, median (range), year 12.4 (1.3, 16.6) 12.2 (1.5, 16.6) 12.7 (1.3, 16.4) 9.4 (3.4, 15.2)
 Females 43.4 45.8 40.5 55.6
 IBD in relatives 17.6 14.6 22.2 17.6
Laboratory values
 Fecal calprotectin > 100 μg/g 88.2 79.4 92.5 100
 Elevated1 ESR and/or CRP 64.9 63.0 64.5 77.8
 Anemia 57.1 44.7 63.6 57.1
 Hypoalbuminemia 43.72 40.73 42.34 62.55
Symptoms
 Abdominal pain 65.4 70.8 62.0 66.7
 Blood in stool 62.5 37.5 77.2 66.7
 Diarrhea 52.2 43.8 59.5 33.3
 Poor growth 34.6 47.9 29.1 11.1
 Constipation 9.6 14.6 7.6 0
 Nausea or vomiting 8.8 10.4 7.6 11.1
 Other6 55.1 58.3 54.4 44.4
  1. IBD, inflammatory bowel disease; CD, Crohn’s disease; UC, ulcerative colitis; IBDU, inflammatory bowel disease undefined; ESR, erythrocyte sedimentation rate; CRP, C-reactive protein. 1ESR > 15 mm/h or CRP > 10 mg. Data was available from all patients in demographic data and symptoms, and in laboratory values from > 80% except in 238, 311, 422 and 55. 6E.g. tiredness, fever, oral symptoms, arthralgia